Comparison of different methods of datscan quantification

Nuclear Medicine Communications

Volumn 26, Issue 12, 2005, Pages 1139-1146

  Morton, Rosemary J ^a   Guy, Matthew J ^b   Clauss, Ralf ^b   Hinton, Paul J ^b   Marshall, Craig A ^b   Clarke, Elizabeth A ^b  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^b GE HEALTHCARE   (United Kingdom)

Author keywords

DaTSCAN; Gamma camera; Parkinson's disease; Quantification

Indexed keywords

BRASS; IOFLUPANE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; COMPUTER PROGRAM; CORPUS STRIATUM; CORRELATION ANALYSIS; ESSENTIAL TREMOR; HUMAN; PARKINSONISM; QUANTISPECT; QUANTITATIVE ANALYSIS;

ALGORITHMS; ESSENTIAL TREMOR; GAMMA CAMERAS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MODELS, STATISTICAL; OBSERVER VARIATION; PARKINSON DISEASE; PHANTOMS, IMAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 27944433086     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200512000-00015     Document Type: Article

References (17)

1. 123I-FP-CIT study group. Mov Disord 2000; 15:503-510.
2. 123I-FP-CIT and SPECT in essential tremor and Parkinson's disease. J Neural Transm 1998; 105:1215-1228.
3. 123I-FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 1997; 62:133-140.
4. Habraken JB, Booji J, Slomka P, Sokole EB, van Royen EA. Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm. J Nucl Med 1999; 40:1091-1097.
5. 123I-FP-CIT SPECT. J Neural Transm 2000; 107:543-552.
6. Radau PE, Slomka PJ, Julin P, Svensson L, Wahlund LO. Evaluation of linear registration algorithms for brain SPECT and the errors due to hypoperfusion lesions. Med Phys 2001; 28:1660-1668.
7. Radau PE, Linke R, Slomka PJ, Tatsch K. Optimization of automated quantification of I123_IBZM uptake in the striatum applied to parkinsonism. J Nucl Med 2000; 41:220-227.
8. Popperl G, Radau P, Linke R, Hahn K, Tatsch K. Diagnostic performance of a 3-D automated quantification method of dopamine D2 receptor SPECT studies in the differential diagnosis of parkinsonism. Nucl Med Commun 2005; 26:39-43.
9. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978; 21:2-20.
10. Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imag 1994; 13:601-609.
11. Carson RE, Yan Y, Chodkowaki BA, Yap TK, Daube-Witherspoon ME. Precision and accuracy of regional radioactivity quantitation using ML EM algorithm. IEEE Trans Nucl Sci 1994; 13:526-537.
12. Fleming JS, Bolt L, Stratford JS, Kemp PM. The specific uptake size index for quantifying radiopharmaceutical uptake. Phys Med Biol 2004; 49:227-234.
13. Costa DC, Walker Z, Dizdarevic S, Ionnides C. Striatal binding of FP-CIT: a simple method to separate Parkinson's disease patients and normal controls. Eur J Nucl Med 1989; 25:1069.
14. Lokkegaard A, Werdelin L, Friberg L. Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand. Eur J Nucl Med 2002; 29:1623-1629.
15. 123I imaging and simultaneous dual-isotope imaging. Nucl Med Commun 2003; 24:1195-1202.
16. Kim KM, Varrone A, Watabe H, Shidahara M, Fujita M, Innis RB, et al. Contribution of scatter and attenuation compensation to SPECT images of nonuniformly distributed brain activities. J Nucl Med 2003; 44:512-519.
17. Weintraub D, Newberg AB, Cary MS, Siderowf AD, Moberg PJ, Kleiner-Fisman G, et al. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. J Nucl Med 2005; 46:227-232.